Corrigendum to "Seroprevalence of Human Betaretrovirus Surface Protein Antibodies in Patients with Breast Cancer and Liver Disease"

J Oncol. 2020 Dec 3:2020:7406146. doi: 10.1155/2020/7406146. eCollection 2020.

Guangzhi Zhang^{1

2}, Kiandokht Bashiri¹, Mark Kneteman¹, Kevan Cave¹, Youngkee Hong¹, John R Mackey³, Harvey J Alter⁴, Andrew L Mason^{1

5}

¹ Center of Excellence for Gastrointestinal Inflammation and Immunity Research, Division of Gastroenterology, University of Alberta, Edmonton AB T6G 2E1, Canada.
² National Microbiology Laboratory, Winnipeg MB R3E 3M4, Canada.
³ Department of Medical Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada.
⁴ Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD 20892, USA.
⁵ Li Ka Shing Institute of Virology, University of Alberta, Edmonton AB T6G 2E1, Canada.

Abstract

[This corrects the article DOI: 10.1155/2020/8958192.].